Get the Stockscreener App
1.15
3.60%
0.04
After Hours:
1.23
0.08
+6.96%
Allarity Therapeutics Inc stock is traded at $1.15, with a volume of 314.28K.
It is up +3.60% in the last 24 hours and down -34.29% over the past month.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
See More
Previous Close:
$1.11
Open:
$1.12
24h Volume:
314.28K
Relative Volume:
0.05
Market Cap:
$16.81M
Revenue:
-
Net Income/Loss:
$-11.90M
P/E Ratio:
-0.00558
EPS:
-206.0125
Net Cash Flow:
$-12.75M
1W Performance:
-20.69%
1M Performance:
-34.29%
6M Performance:
+11.65%
1Y Performance:
-17.86%
1-Day Range:
$1.08
$1.2389
1-Week Range:
$1.08
$1.43
52-Week Range:
$0.6138
$2.35
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Name
Allarity Therapeutics Inc
Sector
Industry
Phone
401-426-4664
Address
24 SCHOOL ST., 2ND FLOOR, BOSTON
Compare ALLR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
1.15 | 16.12M | 0 | -11.90M | -12.75M | -206.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Ascendiant Capital Markets | Buy |
Allarity Therapeutics Inc Stock (ALLR) Latest News
How Allarity Therapeutics Inc. stock reacts to oil prices2025 Earnings Impact & Consistent Return Investment Signals - newser.com
Risk adjusted return profile for Allarity Therapeutics Inc. analyzedEarnings Beat & Growth Focused Stock Reports - newser.com
Exit strategy if you’re trapped in Allarity Therapeutics Inc.2025 Momentum Check & High Accuracy Investment Signals - newser.com
Why Allarity Therapeutics Inc. stock appeals to analystsExit Point & AI Powered Buy/Sell Recommendations - newser.com
Why hedge funds are buying Allarity Therapeutics Inc. stock2025 Market Outlook & Fast Momentum Stock Entry Tips - newser.com
Will Allarity Therapeutics Inc. stock continue upward momentumVolume Spike & Short-Term Trading Alerts - newser.com
Real time breakdown of Allarity Therapeutics Inc. stock performanceWeekly Trade Report & Smart Investment Allocation Tips - newser.com
Applying sector rotation models to Allarity Therapeutics Inc.Weekly Trade Recap & Breakout Confirmation Alerts - newser.com
Published on: 2025-11-06 12:45:18 - newser.com
Why retail investors pile into Allarity Therapeutics Inc. stockJuly 2025 Final Week & Reliable Momentum Entry Alerts - newser.com
Can momentum traders help lift Allarity Therapeutics Inc.2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com
What earnings revisions data tells us about Allarity Therapeutics Inc.Market Activity Report & Growth Oriented Trade Recommendations - newser.com
Can Allarity Therapeutics Inc. stock deliver surprise earnings beat2025 Price Targets & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-11-05 23:50:34 - newser.com
Is it too late to sell Allarity Therapeutics Inc.Options Play & Verified Swing Trading Watchlist - newser.com
Can Allarity Therapeutics Inc. stock outperform in 2025 bull marketRate Hike & Precise Swing Trade Alerts - fcp.pa.gov.br
Is Allarity Therapeutics Inc. stock affected by interest rate hikesIndex Update & Technical Pattern Based Buy Signals - newser.com
Using AI based signals to follow Allarity Therapeutics Inc.Quarterly Trade Report & Trade Opportunity Analysis Reports - newser.com
What analyst consensus says on Allarity Therapeutics Inc. stockBuy Signal & Community Verified Trade Alerts - newser.com
What hedge fund activity signals for Allarity Therapeutics Inc. stock2025 Market WrapUp & Reliable Entry Point Trade Alerts - fcp.pa.gov.br
Will Allarity Therapeutics Inc. stock deliver strong dividend growthInsider Selling & AI Enhanced Trading Alerts - newser.com
Using economic indicators to assess Allarity Therapeutics Inc. potential2025 Market Sentiment & AI Driven Stock Movement Reports - newser.com
How Allarity Therapeutics Inc. stock performs in weak economyJuly 2025 Fed Impact & Safe Investment Capital Preservation Plans - newser.com
Why Allarity Therapeutics Inc. stock is favored by top institutionsTrade Exit Report & Comprehensive Market Scan Insights - newser.com
Using data filters to optimize entry into Allarity Therapeutics Inc.Earnings Beat & Technical Buy Zone Confirmation - newser.com
Real time pattern detection on Allarity Therapeutics Inc. stockQuarterly Earnings Summary & Community Supported Trade Ideas - newser.com
Applying big data sentiment scoring on Allarity Therapeutics Inc.Chart Signals & Safe Entry Point Alerts - newser.com
What technical signals suggest for Allarity Therapeutics Inc. stock2025 Trade Ideas & Verified Short-Term Plans - newser.com
Allarity Therapeutics Inc Stock (ALLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):